CME Presentations

B-cell Non-Hodgkin Lymphomas


Presentations


Speakers

  • Jennifer Santamala, PharmD, BCOP

    Jennifer Santamala, PharmD, BCOP

    Jennifer Santamala, PharmD, BCOP

    Clinical Pharmacy Manager, Hematology/Oncology

    Jennifer Santamala, PharmD, BCOP, is the clinical pharmacy manager, hematology/oncology, at New York-Presbyterian Hospital – Weill Cornell Medical Center. She received her doctor of pharmacy degree from Philadelphia College of Pharmacy in Pennsylvania. Dr Santamala completed a PGY-1 pharmacy residency at Lancaster General Health in Lancaster, Pennsylvania, and then moved to New York to complete her PGY-2 hematology/oncology residency at New York-Presbyterian Hospital, where she has been working ever since.
  • Orel Agami, PA

    Orel Agami, PA

    Orel Agami, PA

    Staff Associate in Medicine

    Orel Agami, PA, is a board-certified physician assistant specializing in hematology/oncology at Weill Cornell Medical College in New York, New York. Ms Agamai earned her bachelor of science degree in biology from the State University of New York at Geneseo. She received her master of science degree in physician assistant studies at Pace University in New York, New York. Ms Agami is certified by the National Commission for Certification of Physician Assistants.
  • John P. Leonard, MD

    John P. Leonard, MD

    John P. Leonard, MD

    Weill Cornell Medicine and NewYork-Presbyterian Hospital

    John P. Leonard, MD, is the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology and associate dean for clinical research at Weill Cornell Medical College in New York. He is vice chairman of the Weill Department of Medicine and associate director of the Meyer Cancer Center at Weill Cornell Medical College and New York Presbyterian Hospital, where he also serves as an attending physician and director of the Joint Clinical Trials Office. His primary research interest is developing novel therapeutic strategies for the treatment of lymphoma and related hematologic malignancies. Dr Leonard is a member of the American Board of Internal Medicine subspecialty board for Hematology, and is chair of the Lymphoma Committee of the Alliance for Clinical Trials in Oncology.

CME Information

Integrating Multidisciplinary Care in the Diagnostic and Therapeutic Management of B-cell Non-Hodgkin Lymphomas


PIM Logo

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Examine the implications of B-cell NHLs as a disease, including accurate diagnosis, risk stratification and molecular biomarkers, to aid prognosis and treatment choice
  • Review the current treatment options available, treatment paradigms, and ongoing clinical trials for patients with B-cell NHLs
  • Plan for a multidisciplinary approach to treatment selection, management of, and practical considerations for patients with B-cell NHL
  • Apply new clinical data to effectively integrate available treatments into the standard of care for patients with B-cell NHLs

Acknowledgement

This activity is supported by independent educational grants from Bayer HealthCare Pharmaceuticals Inc.; Celgene Corporation; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Tuition

Complimentary

Accreditation Statement

The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements

Physician Continuing Education
Live Internet Activity

Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

The American Academy of Nurse Practitioners (AANP) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Date of Releasae/Expiration

Live Activity
Wednesday, February 27, 2019 from 12:00pm – 1:00pm EST.

Enduring Material
The enduring material will be available from February 27, 2019 to August 27, 2019.

Intended Audience

This activity is intended for hematologists, oncologists, hematology-oncology advanced practice providers and nurses, pharmacists, and other clinicians interested/involved in the management of patients with NHL.

Estimated Time to Complete

This activity consists of one session which should take approximately 1 hour to complete.

Method of Participation

There are no fees to participate in this activity. To participate in the activity, go to www.OMedlive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Faculty Disclosure

The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

Presenter

John P. Leonard, MD
Consulting Fees: ADC Therapeutics, AstraZeneca, Bayer, BeiGene, Biotest, Celgene, Karyopharm, MEI Pharma, Merck, MorphoSys, Nordic Nanovector, Novartis, Roche/Genentech, Sandoz, Sutro

Orel Agami, PA
Has nothing to disclose relevant to this activity.

Jennifer Santamala, PharmD, BCOP
Has nothing to disclose relevant to this activity.

Peer Reviewer

Amit Verma, MBBS
Consulting Fee: Celgene, Stelexis

Victor B. Hatcher, PhD
Has nothing to disclose relevant to this activity

Providers

Einstein-Montefiore Center for Continuing Medical Education
The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

PlatformQ Health Education, LLC

Agnes Lee
Medical Director
PlatformQ Health Education, LLC

Has nothing to disclose relevant to this activity.

Alissa Yost
Senior Program Manager

Has nothing to disclose relevant to this activity.

Disclaimers (if applicable):

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, OMedLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Contact Information

Accreditation Support:
Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.

Technical Support:
For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com